iData’s European gastrointestinal endoscopic devices MedSuite covers 10 markets including the enteral feeding devices market, and hemostasis devices market. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s U.S. gastrointestinal endoscopic devices MedSuite covers 11 markets including the enteral feeding devices market, and hemostasis devices market. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s China gastrointestinal endoscopy device MedSuite covers 6 markets including the GI endoscopes, capsule endoscopes, stenting device markets. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s global gastrointestinal endoscopic device MedSuite covers 7 markets including the stenting and dilation and anti-reflux markets. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

Overall, the global endoscopic retrograde cholangiopancreatography (ERCP) device market was valued at nearly $1.7 billion in 2021. This is expected to increase over the forecast period at a CAGR of 6.1% to reach nearly $2.6 billion. The full report suite on the global market for ERCP devices includes sphincterotomes, biliary stone removal balloons, biliary stone

The full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options. For example, the stenting and dilation devices that are now used for patients that would have had to undergo surgical intervention in the past. The other emerging trend is related to challenges with the infection control for the GI devices that now are making inroads for growing popularity of the single-use devices, even on the originally capital equipment type of devices such as scopes.